Fanconi Anemia clinical trials at UC Davis

1 research study open to eligible people

Activity of DSB2455 in Participants With Advanced Malignancies
open to eligible people ages 18 years and up
Open label, multi-centre, Phase Ia/b adaptive design study with an initial 2-stage Dose Escalation Phase followed by a Dose Expansion Phase.
Sacramento, California and other locations

Last updated: September 1, 2026